Overview
- The UK’s science ministry has drawn up proposals for Anthropic that include a larger London office and a possible dual listing to be pitched to CEO Dario Amodei during his late‑May visit.
- Officials described a UK share listing alongside a US float as “the dream,” yet the same sources said it is unlikely.
- The outreach follows a US defense clash that brought a Pentagon supply‑chain‑risk label, a court order that paused the blacklisting, and continuing litigation.
- President Donald Trump criticized the company after it held firm on red lines that bar uses such as autonomous weapons and US surveillance.
- The push fits a wider UK drive for sovereign AI capacity, including a new £40 million public research lab and efforts to lure top labs to expand in London.